Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Nettersheim

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Matrix Biology : Journal of the International Society for Matrix Biology|June 8, 2024
Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophagesAlexa Stephan, Jan-Henrik Suhrmann, Margaretha A Skowron, et al.
NPJ Precision Oncology|March 31, 2026
Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancersLara Marson, Margaretha A Skowron, Pailin Pongratanakul, et al.
The FEBS Journal|May 31, 2023
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partnersChristian Söhngen, David J Thomas, Margaretha A Skowron, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2021
The component of the m<sup>6</sup>A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al.
Cancers|October 14, 2020
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, et al.
Cancer Letters|January 31, 2024
Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkersPailin Pongratanakul, Felix Bremmer, Stella Pauls, et al.
Molecular Cancer Therapeutics|August 24, 2022
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological MalignanciesAaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, et al.
Cell Death Discovery|March 9, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2Laura Schmitt, Ilka Lechtenberg, Daniel Drießen, et al.
Molecular Oncology|July 11, 2022
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome levelMargaretha A Skowron, Katharina Eul, Alexa Stephan, et al.
Molecular Oncology|July 22, 2021
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomasMargaretha A Skowron, Teresa K Becker, Lukas Kurz, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Matrix Biology : Journal of the International Society for Matrix Biology|June 8, 2024
Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophagesAlexa Stephan, Jan-Henrik Suhrmann, Margaretha A Skowron, et al.
NPJ Precision Oncology|March 31, 2026
Targeting histone deacetylation, cell cycle regulators and heat shock proteins as novel therapeutic strategies for penile cancersLara Marson, Margaretha A Skowron, Pailin Pongratanakul, et al.
The FEBS Journal|May 31, 2023
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partnersChristian Söhngen, David J Thomas, Margaretha A Skowron, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2021
The component of the m<sup>6</sup>A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al.
Cancers|October 14, 2020
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, et al.
Cancer Letters|January 31, 2024
Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkersPailin Pongratanakul, Felix Bremmer, Stella Pauls, et al.
Molecular Cancer Therapeutics|August 24, 2022
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological MalignanciesAaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, et al.
Cell Death Discovery|March 9, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2Laura Schmitt, Ilka Lechtenberg, Daniel Drießen, et al.
Molecular Oncology|July 11, 2022
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome levelMargaretha A Skowron, Katharina Eul, Alexa Stephan, et al.
Molecular Oncology|July 22, 2021
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomasMargaretha A Skowron, Teresa K Becker, Lukas Kurz, et al.
Pageof 8